Regxia Inc

placeholder+image
About US:

Regxia is a unique scientific and regulatory consulting firm servicing the pharmaceutical and biotech industries. With a primary focus of collaborating with our customers, we provide knowledge, experience and innovation. Regxia - Your partner throughout all phases of development and marketing.

Web Site: www.regxia.com; www.regxiatraining.com; www.Regxia.com/blog
Address:

5-133 The West Mall
Toronto, M9C 1C2
Canada
Phone: 416-620-5236
Fax: 416-620-0261
Email: mcgregor@regxia.com

Contact:

Betty Cory
President

Lori Steinhoff
Director

Geographic Areas: Australia/Oceania
Australia
New Zealand
Europe
North America
Canada
United States
Business Type: Consulting Services
Products: Biologics
Blood 
Vaccines
Allergenic
Cellular & Gene Therapy
Tissues
Combination Product
Medical Devices
Class I
Class II
Class III
Drugs 
Patent Drug/New Drug/Brand Name Drugs
Generic Drugs
Orphan Drugs
Over-the-Counter (OTC)
Professional Responsibility (Production): Conception and Development
Submission/Registrations
Professional Responsibility (Regulatory Process): Good Clinical Practice (GCP)
Biological License Approval (BLA)
Investigational New Drug (IND)
New Drug Approval (NDA)
Premarket Approval (PMA)
Premarket Notification (510k)